Gland Pharma Schedules One-on-One Investor Meeting with ADIA
Gland Pharma Ltd 路 Intimation 路 17 Nov 2026, 10:43 pm
Gland Pharma Schedules One-on-One Investor Meeting with ADIA Gland Pharma Limited has announced a schedule for an upcoming institutional investor interaction. The company is slated to participate in a one-on-one meeting with ADIA (Abu Dhabi Investment Authority) on 20th Nov'26. The company noted that the schedule remains subject to change depending on exigencies from either party.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
- Unaudited Financial Results for the Quarter and half year ended September 30, 2026 路 06 Nov 2026
